GeoVax Develops Multi-Antigen COVID-19 Vaccine Targeting Immunocompromised Populations
GeoVax's innovative GEO-CM04S1 vaccine addresses critical gaps in COVID-19 immunization strategies by offering broad, durable protection for vulnerable populations as HHS shifts towards risk-based vaccine recommendations.
